Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

After pulmonary embolism:
recovery, follow-up, activity and recurrence risk

After a pulmonary embolism recovery is not the same for everyone. Some people return quickly to normal activities, whereas others continue for weeks or months to experience shortness of breath, fatigue or reduced exercise tolerance. Most patients need to continue an anticoagulant for at least 3 months and undergo reassessment to decide whether to stop or continue it.
If recovery is favorable and there are no symptoms, it is not normally necessary to repeat a CT scan merely to check whether the thrombus has disappeared. Persistent or new breathlessness, reduced exercise capacity, signs of recurrence or problems related to anticoagulants do, however, warrant further investigation.

Recovery is therefore not simply a matter of passively waiting for the clot to be absorbed. It involves adherence to treatment, gradual resumption of activity, control of risk factors and clinical reassessment, often particularly important around 3–6 months after the event.

The main points to know are:


How long recovery takes after pulmonary embolism

During the first days and weeks, fatigue, breathlessness during activities that were previously easy, reduced stamina and fear of physical exertion are common. Improvement may be rapid after a small, low-risk embolism, but it may take longer when the event was extensive, caused right ventricular strain or occurred in a person with other heart or respiratory diseases.
There is therefore no single number of days that applies to everyone. The practical goal is to observe a progressive trend toward improvement, not to expect an immediate return to the previous level of performance.

A substantial proportion of people report functional limitations some time after the event. The term post-pulmonary embolism syndrome is used to describe dyspnea, reduced exercise tolerance or worsening functional status that persist after at least 3 months of adequate anticoagulation and are not explained by other conditions.
This does not automatically mean that a large thrombus remains in the pulmonary arteries. Deconditioning, pre-existing heart or respiratory disease, anemia, anxiety and other causes can contribute to symptoms and must be considered during follow-up.

Anticoagulants and follow-up: what happens in the first few months

Anticoagulant treatment must be taken exactly as prescribed. Missing doses, reducing them without medical advice or stopping the medicine because one feels better can increase the risk of recurrence. At the same time, anticoagulants increase bleeding risk, so follow-up visits reassess adherence, dosage, kidney or liver function when relevant, interactions with other medicines and factors that may increase bleeding risk.
For a confirmed acute pulmonary embolism, anticoagulant treatment generally lasts at least 3 months. After that, the decision varies from person to person.

If the embolism was caused by a major transient factor that has since resolved, such as certain surgical procedures or a substantial period of immobility, future risk may differ from that of an event without an obvious cause or associated with a persistent factor. The clinician therefore compares recurrence risk and bleeding risk before deciding whether to stop, extend or continue anticoagulation long term.
Thrombophilia testing or extensive cancer investigations are not carried out indiscriminately in every patient. Their usefulness depends on age, personal and family history, the characteristics of the event and whether the results could actually change management.

Physical activity, work and everyday life after pulmonary embolism

Remaining completely immobile for weeks does not promote recovery. After discharge, in clinically stable people, it is generally appropriate to resume movement gradually, starting with activities that can be tolerated and progressively increasing their duration and intensity. Regular walking can help limit deconditioning, but the pace of recovery must take account of symptoms, functional capacity and the instructions provided at discharge.
Intense exertion requires greater caution immediately after the event. If the embolism caused right ventricular dysfunction, cardiac recovery may take days or weeks, and the clinician may consider reassessment useful before strenuous activities.

Returning to work depends on the type of occupation and clinical course. Sedentary work may be resumed sooner than physically demanding work, but spending many consecutive hours sitting also calls for breaks and regular movement.
During anticoagulation, the risk of injury and bleeding must also be considered. Contact sports, activities with a high risk of falling or work involving possible injuries may require restrictions or individual assessment. For flights and long journeys in the first weeks after pulmonary embolism, especially after more severe events, it is advisable to seek specific advice before departure.

Breathlessness that does not resolve: when further investigations are necessary

Some breathlessness during recovery may be compatible with the healing process, but persistent, new or progressive dyspnea deserves assessment. European guidelines recommend reassessment after approximately 3–6 months precisely to identify people with continuing functional limitations and decide whether further testing is needed.
Depending on the clinical picture, echocardiography, functional tests, ventilation/perfusion scintigraphy, CT pulmonary angiography or other investigations may be used. Not everyone needs these tests: the pathway is chosen on the basis of symptoms and clinical probability.

An uncommon but important complication is chronic thromboembolic pulmonary disease, which includes forms with or without pulmonary hypertension. It should be considered especially when breathlessness and reduced exercise capacity persist after treatment of the acute event.
Most patients with residual symptoms do not have chronic thromboembolic pulmonary hypertension, but recognizing it early is important because expert centers offer specific diagnostic pathways and treatments.

When to seek help during recovery

Sudden deterioration with significant new shortness of breath, chest pain, fainting, a very rapid heartbeat or coughing up blood may indicate recurrent pulmonary embolism or another emergency and requires immediate assessment. These symptoms must not automatically be attributed to the previous embolism or to anxiety.
New pain and marked swelling in one leg may also indicate new deep vein thrombosis and must be assessed promptly.

Bleeding also requires attention during anticoagulation. Heavy bleeding or bleeding that does not stop, visible blood in stools or vomit, black stools, a sudden severe headache, loss of consciousness or significant head injury require urgent care. Recurrent minor bleeding, periods that are much heavier than usual or frequent bruising should instead be reported to the clinician without changing treatment independently.
The practical rule is simple: do not stop the anticoagulant on your own, but seek advice when problems arise or when new medicines, including over-the-counter products, are to be started.

Frequently asked questions after pulmonary embolism

How long does it take to recover?
There is no single recovery time. Some people improve markedly within a few weeks, while others experience fatigue or shortness of breath for months. What matters most is progressive recovery and reassessment of persistent symptoms.

Should CT be repeated to check that the clot has disappeared?
Not routinely if there are no symptoms and recovery is favorable. Follow-up examinations are requested when they may change management, for example in the presence of persistent dyspnea or suspected chronic thromboembolic disease.

When can I start playing sports again?
Activity is generally resumed gradually after discharge. Intense exertion requires more caution, especially after an embolism associated with right ventricular strain. Sports with a high risk of injury are problematic during anticoagulation.

How long do I need to take the anticoagulant?
Generally at least 3 months. After that, duration depends on the cause of the embolism, the likelihood of recurrence and bleeding risk.

Is shortness of breath after 3 months normal?
It may persist in some people, but should not simply be ignored. If it continues to limit activities, reassessment is indicated to investigate the cause and, when necessary, exclude chronic thromboembolic complications.

Bibliography
  1. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405.
  2. Klok FA, Ageno W, Ay C, et al. Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society. European Heart Journal. 2022;43(3):183-189. doi:10.1093/eurheartj/ehab816.
  3. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2022;43(38):3618-3731. doi:10.1093/eurheartj/ehac237.
  4. National Institute for Health and Care Excellence. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE guideline NG158. Published 2020, updated 2023, reviewed 2026.
  5. Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism. Blood Advances. 2020;4(19):4693-4738. doi:10.1182/bloodadvances.2020001830.
  6. Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545-e608. doi:10.1016/j.chest.2021.07.055.
  7. Kahn SR, Hirsch AM, Akaberi A, et al. Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study. Chest. 2017;151(5):1058-1068. doi:10.1016/j.chest.2016.11.030.
  8. Pugliese SC, Kawut SM. The Post-Pulmonary Embolism Syndrome: Real or Ruse? Annals of the American Thoracic Society. 2019;16(7):811-814. doi:10.1513/AnnalsATS.201901-061PS.
  9. Prandoni P, Lensing AWA, Prins MH, et al. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Annals of Internal Medicine. 2009;150(9):577-585. doi:10.7326/0003-4819-150-9-200905050-00003.
  10. Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. Journal of Thrombosis and Haemostasis. 2016;14(7):1480-1483. doi:10.1111/jth.13336.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.